Clinical Specialty

• Pharmacokinetics

Education

• PhD, Long Island University, NY; 2008
• MD, Azerbaijan Government Medical; 1994

Honors and Awards

• Research award, 2013, Touro
• OSP Faculty Research Fund Award, 2012-2013
• AAPS Appreciation Certificate, 2008
• Pharmaceutical Honor Society Award of Beta Cheta Chapter, the Rho Chi Society, 2004 and 2008

Research

• The gender differences in renal excretion of organic cations
• Protein binding drug-drug interaction

Recent Publications

• Mullokandov E, Ahn J, Szalkiewicz A and Babayeva M. Protein Binding Drug-Drug Interaction between Warfarin and Tizoxanide in Human Plasma. Austin J Pharmacol Ther. 2014; 2 (7).3
• Mariana Babayeva, Malka Fuzailov, Paulina Rozenfeld and Paramita Basu. Marijuana Compounds: A Non-Conventional Therapeutic Approach to Epilepsy in Children. J Addict Neuropharmacol, 2014
• Jian Jiang, Joshua McCoy, Min Shen, Christopher LeClair, Wenwei Huang, Ana Negri, Jihong Li, Robert Blue, Amanda Weil Harrington, Sarasija Naini, George David III, Won-Seok Choi, Elisabetta Volpi, Joseph Fernandez, Mariana Babayeva, Mark A. Nedelman, Marta Filizola, Barry S. Coller, Craig J. Thom. “A novel class of ion displacement ligands as antagonists of the aIIbb3 receptor that limit conformational reorganization of the receptor.” Bioorganic & Medicinal Chemistry Letters, 2014
• White M, Babayeva M, Taft D, Maniar M. "Determination of Intestinal Permeability of Rigosertib (ON 01910.Na, Estybon™): Correlation with Systemic Exposure", Journal of Pharmacy and Pharmacology, July 2013
• Babayeva M, White M., Cox S, Taft D.”Renal Excretion of Apricitabine in Rats: Ex Vivo and In vivo Studies.” European Journal of Drug Metabolism and Pharmacokinetics, Sep 2011
• Dr. Taft, Dontabhaktuni A, Babayeva M, Nakatani-Freshwater T, Savant I. “Application of the isolated perfused rat kidney model to assess gender effects on drug excretion.” Drug Development and Industrial Pharmacy, Sept 2006
• Nakatani T, Babayeva M, Dontabhaktuni A, Taft DR. “Effect of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and lamivudine in the isolated perfused rat kidney.” Journal of Pharmacology and Experimental Therapeutics, Aug 2006

Professional Service

• Adjunct Faculty,  The Rockefeller University,  New York, NY, 08/12-present
• Visiting Scientist, LIU, Brooklyn, NY, 06/08 – present
• Invited Instructor, UNC, Chapel Hill, NC, 08/09 – 08/13

Teaching Responsibilities

• Fall Core Course, PY1: FOUNDATIONS OF PHARMACEUTICAL SCIENCES I (PHRM 503) 
• Spring Core Course, PY1: FOUNDATIONS OF PHARMACEUTICAL SCIENCES II, Dosage Forms (PHRM #509)
• Fall Core Course, PY2: Clinical Pharmacokinetics (PHRM #635)
• Spring Core Course, PY2: Pharmacogenomics/Interaction (PHRM#636)
• Elective Course “Introduction to Pharmacometrics”
• Elective Course “Advanced Pharmacy Practice: Non-Direct Patient Care”

Hobbies

Family